A detailed history of Vantage Financial Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vantage Financial Partners, LLC holds 415 shares of LLY stock, worth $330,203. This represents 0.1% of its overall portfolio holdings.

Number of Shares
415
Previous 415 -0.0%
Holding current value
$330,203
Previous $375,000 2.13%
% of portfolio
0.1%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $12,322 - $15,453
17 Added 4.27%
415 $375,000
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $2,961 - $3,961
5 Added 1.27%
398 $309,000
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $44,641 - $52,626
-85 Reduced 17.78%
393 $229,000
Q3 2023

Nov 02, 2023

BUY
$434.7 - $599.3 $434 - $599
1 Added 0.21%
478 $256,000
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $167,302 - $223,703
477 New
477 $223,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vantage Financial Partners, LLC Portfolio

Follow Vantage Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Financial Partners, LLC with notifications on news.